Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EVAX Evaxion Biotech A/S

Post-Market Trading 09-27 19:09:22 EDT

3.12

+0.06

+1.96%

盘后3.11

-0.01-0.32%

19:03 EDT

High3.22	Low3.00	Vol88.04K
Open3.10	D1 Closing3.06	Amplitude7.15%
Mkt Cap17.40M	Tradable Cap10.78M	Total Shares5.58M
T/O272.96K	T/O Rate2.55%	Tradable Shares3.46M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"EVAX","market":"US","secType":"STK","nameCN":"Evaxion Biotech A/S","latestPrice":3.12,"timestamp":1727467200000,"preClose":3.06,"halted":0,"volume":88038,"hourTrading":{"tag":"盘后","latestPrice":3.11,"preClose":3.12,"latestTime":"19:03 EDT","volume":98,"amount":305.2299768,"timestamp":1727478211604},"delay":0,"floatShares":3455885,"shares":5576054,"eps":-3.860519,"marketStatus":"Post-Market Trading","change":0.06,"latestTime":"09-27 19:09:22 EDT","open":3.1,"high":3.22,"low":3.0012,"amount":272960.322354,"amplitude":0.071503,"askPrice":3.12,"askSize":30,"bidPrice":3,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-3.860519,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1727481600000},"marketStatusCode":4,"adr":0,"adrRate":10,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":3.06,"preHourTrading":{"tag":"盘前","latestPrice":2.92,"preClose":3.06,"latestTime":"08:43 EDT","volume":1763,"amount":5159.5600111,"timestamp":1727441018888},"postHourTrading":{"tag":"盘后","latestPrice":3.11,"preClose":3.12,"latestTime":"19:03 EDT","volume":98,"amount":305.2299768,"timestamp":1727478211604},"volumeRatio":0.494857,"impliedVol":2.1042,"impliedVolPercentile":0.0833},"requestUrl":"/m/hq/s/EVAX/tweets","defaultTab":"tweets","newsList":[{"id":"2470751932","title":"Evaxion Biotech Price Target Maintained With a $14.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2470751932","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470751932?lang=en_us&edition=fundamental","pubTime":"2024-09-27 00:05","pubTimestamp":1727366700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EVAX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 26, 2024 12:05 ET (16:05 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX"],"gpt_icon":0},{"id":"2470751520","title":"Evaxion Biotech deal underscores potential of AI models, says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2470751520","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470751520?lang=en_us&edition=fundamental","pubTime":"2024-09-26 23:55","pubTimestamp":1727366108,"startTime":"0","endTime":"0","summary":"Evaxion (EVAX) has entered into an option and licensing agreement with Merck (MRK) for its preclinical vaccine candidates EVX-B2 and EVX-B3, under ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/evaxion-biotech-deal-underscores-potential-of-ai-models-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/evaxion-biotech-deal-underscores-potential-of-ai-models-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0058720904.USD","IE00BBT3K403.USD","IE00B2B36J28.USD","LU1037948541.HKD","LU0265550946.USD","LU0965509283.SGD","LU1116320737.USD","IE00BLSP4452.SGD","LU1093756168.USD","LU0320765489.SGD","LU1037948897.HKD","EVAX","LU0122379950.USD","BK4533","IE00BSNM7G36.USD","MRK","LU0861579265.USD","IE00BFTCPJ56.SGD","LU0965508806.USD","LU0289739699.SGD","LU1934455194.USD","LU0985320562.USD","IE00B4R5TH58.HKD","LU0965509101.SGD","IE00BLSP4239.USD","LU1291159041.SGD","LU0965509010.AUD","IE00BJT1NW94.SGD","LU0238689110.USD","LU1057294990.SGD","LU1116320901.HKD","IE00B1BXHZ80.USD","LU1585245621.USD","LU1941712264.USD","LU1066051811.HKD","BK4139","LU1023059063.AUD","LU1934455277.USD","LU0203347892.USD","LU0208291251.USD","BK4588","LU1430594728.SGD","LU1917777945.USD","LU0106261372.USD","LU0006306889.USD","LU0070302665.USD","LU0266013472.USD","IE00BN8TJ469.HKD","LU0234572021.USD","BK4534"],"gpt_icon":0},{"id":"2470873610","title":"Evaxion Biotech (EVAX) Gets a Buy from Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2470873610","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470873610?lang=en_us&edition=fundamental","pubTime":"2024-09-26 20:56","pubTimestamp":1727355387,"startTime":"0","endTime":"0","summary":"In a report released today, Thomas Flaten from Lake Street maintained a Buy rating on Evaxion Biotech (EVAX – Research Report), with a price target...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/evaxion-biotech-evax-gets-a-buy-from-lake-street?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/evaxion-biotech-evax-gets-a-buy-from-lake-street?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2470733303","title":"Evaxion Biotech Bolsters MSD Vaccine Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2470733303","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470733303?lang=en_us&edition=fundamental","pubTime":"2024-09-26 20:27","pubTimestamp":1727353669,"startTime":"0","endTime":"0","summary":"Evaxion Biotech (EVAX) has released an update. Evaxion Biotech has expanded its partnership with pharmaceutical giant MSD, providing MSD with the o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-bolsters-msd-vaccine-collaboration?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-bolsters-msd-vaccine-collaboration?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2470578738","title":"Evaxion Biotech Grants Merck Option to License Vaccine Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2470578738","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470578738?lang=en_us&edition=fundamental","pubTime":"2024-09-26 20:20","pubTimestamp":1727353207,"startTime":"0","endTime":"0","summary":"Evaxion Biotech  said Thursday it granted Merck  an option to exclusively license two preclinical vaccine candidates, EVX-B2 and EVX-B3.If Merck exercises the option to license either one or both candidates, Evaxion will receive $3.2 million upfront and up to $10 million in 2025, Evaxion said.Evaxion said it is also eligible for milestone payments of up to $592 million per product.EVX-B2 is a protein-based candidate for gonorrhea and EVX-B3, co-developed with Merck, targets an undisclosed infectious agent.Evaxion was up more than 6%, while Merck was trading fractionally higher in pre-bell Thursday.Price: 3.1000, Change: +0.18, Percent Change: +6.16","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B2B36J28.USD","IE00B1BXHZ80.USD","IE00BBT3K403.USD","LU1061106388.HKD","LU1093756168.USD","LU1291159041.SGD","IE00BJJMRZ35.SGD","LU1066051498.USD","BK4588","IE00B4R5TH58.HKD","LU0208291251.USD","LU0289739699.SGD","LU1917777945.USD","LU1934455863.HKD","IE000M9KFDE8.USD","LU0058720904.USD","LU0070302665.USD","LU0122379950.USD","LU1116320737.USD","LU0985320562.USD","LU0965509283.SGD","LU1037948897.HKD","BK4550","LU0203345920.USD","IE0009355771.USD","LU1037948541.HKD","IE00BLSP4452.SGD","IE00BN8TJ469.HKD","LU1066053197.SGD","BK4007","BK4585","LU1066051811.HKD","LU0265550359.USD","LU0965509101.SGD","IE00BFTCPJ56.SGD","LU0238689110.USD","LU0106261372.USD","IE00BLSP4239.USD","LU1057294990.SGD","LU1934455277.USD","BK4533","LU0203347892.USD","LU0006306889.USD","LU0266013472.USD","LU0965509010.AUD","MRK","EVAX","BK4139","IE00BJT1NW94.SGD","LU0965508806.USD"],"gpt_icon":0},{"id":"2470847780","title":"Evaxion stock jumps on expanded vaccine development pact with MSD","url":"https://stock-news.laohu8.com/highlight/detail?id=2470847780","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470847780?lang=en_us&edition=fundamental","pubTime":"2024-09-26 19:57","pubTimestamp":1727351854,"startTime":"0","endTime":"0","summary":"Evaxion Biotech  shares gained roughly 17% in early trade on Thursday after the company announced an expansion of its vaccine development collaboration with MSD  . Pursuant to the deal, Evaxion has granted MSD an option to exclusively license Evaxion’s preclinical, AI-designed vaccine candidates EVX-B2, a protein-based candidate for Gonorrhea, and EVX-B3. The two companies have been collaborating on EVX-B3, which targets an undisclosed infectious agent, since 2023. In return, Evaxion receives an upfront payment of $3.2M and up to $10M in 2025, contingent upon MSD exercising its option to license either one or both candidates. It is also eligible for development, regulatory and sales milestone payments with a potential value of up to $592M per product, as well as royalties on net sales. The agreement expands the companies’ current collaboration and carries significant value for Evaxion. Last year, MSD, through its Global Health Innovation Fund, led a private financing round for Evaxion ","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1316007813/image_1316007813.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1316007813/image_1316007813.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4153626-evaxion-stock-jumps-on-expanded-vaccine-development-pact-with-msd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["EVAX","MRK","LU0058720904.USD","BK4007","LU0289739699.SGD","IE00BLSP4239.USD","LU0211331839.USD","LU0985320562.USD","BK4588","IE00BN8TJ469.HKD","LU0265550946.USD","LU0208291251.USD","LU1066051498.USD","IE00BLSP4452.SGD","LU1037948897.HKD","IE000M9KFDE8.USD","LU0106261372.USD","LU0203347892.USD","LU1066051225.USD","LU1023059063.AUD","LU1934455863.HKD","LU1291159041.SGD","IE00BSNM7G36.USD","LU0238689110.USD","LU0122379950.USD","IE00B1BXHZ80.USD","LU1066053197.SGD","LU0965508806.USD","IE00BBT3K403.USD","LU1066051811.HKD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU1061106388.HKD","LU1093756325.SGD","LU0203345920.USD","LU0965509283.SGD","BK4550","LU1934455194.USD","BK4516","IE00BJT1NW94.SGD","LU1585245621.USD","LU0006306889.USD","LU0266013472.USD","IE0009355771.USD","LU0265550359.USD","LU1037948541.HKD","IE00BFTCPJ56.SGD","BK4585","LU0234572021.USD","BK4139"],"gpt_icon":0},{"id":"2470787381","title":"BRIEF-Evaxion Significantly Expands Vaccine Development Collaboration With MSD","url":"https://stock-news.laohu8.com/highlight/detail?id=2470787381","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470787381?lang=en_us&edition=fundamental","pubTime":"2024-09-26 19:45","pubTimestamp":1727351129,"startTime":"0","endTime":"0","summary":"Sept 26  - Evaxion Biotech A/S   :   * EVAXION SIGNIFICANTLY EXPANDS VACCINE DEVELOPMENT COLLABORATION WITH MSD   * EVAXION BIOTECH A/S - ENTERS OPTION AND LICENSE AGREEMENT WITH MSD   * EVAXION BIOTECH A/S - MSD GRANTED OPTION TO LICENSE EVAXION'S EVX-B2 AND EVX-B3   * EVAXION BIOTECH A/S - TO RECEIVE $3.2 MILLION UPFRONT, UP TO $10 MILLION IN 2025   * EVAXION BIOTECH A/S - ELIGIBLE FOR UP TO $592 MILLION PER PRODUCT IN MILESTONESSource text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2470782088","title":"Evaxion Biotech expands vaccine development collab with Merck","url":"https://stock-news.laohu8.com/highlight/detail?id=2470782088","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470782088?lang=en_us&edition=fundamental","pubTime":"2024-09-26 19:35","pubTimestamp":1727350545,"startTime":"0","endTime":"0","summary":"Evaxion Biotech (EVAX) announced that it has entered into an option and license agreement with MSD (MRK) for two preclinical vaccine candidates. Th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/evaxion-biotech-expands-vaccine-development-collab-with-merck?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/evaxion-biotech-expands-vaccine-development-collab-with-merck?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0265550946.USD","LU1941712264.USD","LU0208291251.USD","BK4533","IE00BBT3K403.USD","LU0289739699.SGD","MRK","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0965509010.AUD","LU1934455194.USD","LU1057294990.SGD","LU1066051811.HKD","IE00B1BXHZ80.USD","LU1585245621.USD","BK4534","LU0238689110.USD","IE00BLSP4239.USD","LU0234572021.USD","EVAX","LU0006306889.USD","LU1037948541.HKD","IE00BSNM7G36.USD","LU0965508806.USD","LU1093756168.USD","IE00BFTCPJ56.SGD","LU1934455277.USD","IE00B4R5TH58.HKD","LU0106261372.USD","LU1023059063.AUD","IE0009355771.USD","IE00BN8TJ469.HKD","BK4007","LU0861579265.USD","BK4559","LU0070302665.USD","LU0320765489.SGD","LU0203347892.USD","LU1917777945.USD","LU0985320562.USD","LU0965509101.SGD","BK4588","LU0266013472.USD","IE00BLSP4452.SGD","LU1291159041.SGD","LU1430594728.SGD","LU1116320901.HKD","LU1116320737.USD","LU0965509283.SGD","LU1037948897.HKD"],"gpt_icon":0},{"id":"2470840487","title":"Evaxion Significantly Expands Vaccine Development Collaboration With Msd","url":"https://stock-news.laohu8.com/highlight/detail?id=2470840487","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470840487?lang=en_us&edition=fundamental","pubTime":"2024-09-26 19:30","pubTimestamp":1727350201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240926:nTUA8VC5V1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2470782852","title":"Evaxion Biotech a/S - Enters Option and License Agreement With Msd","url":"https://stock-news.laohu8.com/highlight/detail?id=2470782852","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470782852?lang=en_us&edition=fundamental","pubTime":"2024-09-26 19:30","pubTimestamp":1727350201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240926:nTUA8VC5V1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2470782837","title":"Evaxion Biotech a/S - Eligible for up to $592 Mln per Product in Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2470782837","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470782837?lang=en_us&edition=fundamental","pubTime":"2024-09-26 19:30","pubTimestamp":1727350201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240926:nTUA8VC5V1:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2470340782","title":"Evaxion significantly expands vaccine development collaboration with MSD","url":"https://stock-news.laohu8.com/highlight/detail?id=2470340782","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470340782?lang=en_us&edition=fundamental","pubTime":"2024-09-26 19:30","pubTimestamp":1727350200,"startTime":"0","endTime":"0","summary":"Agreement provides MSD with options to license Evaxion’s preclinical, AI-designed vaccine candidates EVX-B2 and EVX-B3Evaxion will host a conference call and webcast to discuss the agreement on Septem","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/09/26/2953697/0/en/Evaxion-significantly-expands-vaccine-development-collaboration-with-MSD.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2470759176","title":"EVAX Process Continues to Garner Interest and Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2470759176","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470759176?lang=en_us&edition=fundamental","pubTime":"2024-09-26 19:07","pubTimestamp":1727348820,"startTime":"0","endTime":"0","summary":"Evaxion  is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting vaccines. The company notes that it has demonstrated that it can identify, through the company's AI models, novel targets within days, rather than the traditional years it commonly takes with standard drug discovery methods. The use of AI also allows the company to decrease the risk of failure as the technology filters out those results that may result in low efficacy or unacceptable toxicity.DISCLOSURE: Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm, engaged","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/evax-process-continues-garner-interest-110700725.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1934455863.HKD","LU1023059063.AUD","MRK","LU0006306889.USD","LU0265550359.USD","LU1061106388.HKD","IE00BLSP4452.SGD","IE00BN8TJ469.HKD","LU1057294990.SGD","LU0965509101.SGD","LU1585245621.USD","LU1037948541.HKD","LU0234572021.USD","LU0122379950.USD","LU0211331839.USD","LU0208291251.USD","LU1066051811.HKD","IE00BJT1NW94.SGD","LU0058720904.USD","LU0106261372.USD","LU1066051498.USD","LU1291159041.SGD","IE00BJJMRZ35.SGD","IE00BSNM7G36.USD","LU0266013472.USD","IE0002141913.USD","BK4559","LU0203347892.USD","LU0070302665.USD","LU0965508806.USD","LU0965509010.AUD","LU0289739699.SGD","IE00B1BXHZ80.USD","LU1934455194.USD","LU1093756325.SGD","LU1934455277.USD","LU1066051225.USD","BK4516","BK4550","LU1093756168.USD","LU1037948897.HKD","IE00BLSP4239.USD","LU0965509283.SGD","IE000M9KFDE8.USD","LU0238689110.USD","EVAX","BK4007","IE00BBT3K403.USD","BK4533","BK4534"],"gpt_icon":0},{"id":"2470269701","title":"European Equities Traded in the US as American Depositary Receipts Trend Lower Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2470269701","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470269701?lang=en_us&edition=fundamental","pubTime":"2024-09-25 23:07","pubTimestamp":1727276829,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were moving lower late Wednesday morning, declining 0.27% to 1,442.84 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies argenx  and Genfit , which rose 4.3% and 3.6% respectively. They were followed by pharmaceutical company Ascendis Pharma  and internet advertising company Criteo , which increased 2.9% and 2% respectively.The decliners from continental Europe were led by biotech firm Evaxion Biotech  and biopharmaceutical company DBV Technologies , which fell 6.3% and 3.2% respectively. They were followed by semiconductor company Sequans Communications  and software vendor SAP , which dropped 3% and 2.4% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics  and Amarin , which advanced 11% and 2% respectively. They were followed by biopharmaceutical company Bicycle Therapeutics  and mining company BHP Gr","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BCYC","BP","GNFT","BK4007","EVAX","SQNS","BK4009","BK7095","BK4168","LU0320765646.SGD","DBVT","ASND","BK4117","BK4585","BHP.AU","NCNA","BK4201","BK4588","IE00BFMHRM44.USD","BK4139","BHP","BK7507","BK4023","LU0109394709.USD","TRIB","LU1162221912.USD","LU0072461881.USD","ARGX","BK7511","LU0162691827.USD","BK4107","BK4141","BK4505","LU0320765992.SGD","BK4082","BK4528","LU1829250122.USD","CRTO","AFG","AMRN","SAP","ADAP","AKTX","LU0889565916.HKD"],"gpt_icon":1},{"id":"2469206604","title":"Evaxion Biotech Names New Interim CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2469206604","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2469206604?lang=en_us&edition=fundamental","pubTime":"2024-09-21 04:58","pubTimestamp":1726865883,"startTime":"0","endTime":"0","summary":"Evaxion Biotech (EVAX) has released an update. Evaxion Biotech has announced the appointment of Thomas Schmidt as the Interim Chief Financial Offic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-names-new-interim-cfo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-names-new-interim-cfo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2468464099","title":"Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing","url":"https://stock-news.laohu8.com/highlight/detail?id=2468464099","media":"GlobeNewswire","labels":["Important Conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468464099?lang=en_us&edition=fundamental","pubTime":"2024-09-20 20:35","pubTimestamp":1726835700,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept. 20, 2024  -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Virtual Investor Forum held September 19th are now available for online viewing. This event was co-sponsored by Zacks Small-Cap Research.The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may downloadinvestor materials from the company’s resource section.Select companies are accepting 1x1 management meeting requests through September 24th.Virtual Investor Conferences  is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.Providing a real-time investor engagement solution, the VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect w","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/pFljWkapktZgUPklKmqXAw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c1bc32f339f4e97512173ec64c4449c0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/pFljWkapktZgUPklKmqXAw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c1bc32f339f4e97512173ec64c4449c0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/life-sciences-virtual-investor-forum-123500670.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Important Conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QID","GENFF","BK4007","EVAX","VNRX","NQmain","CHRO","PSQ","ACST","TQQQ","BK4139","QLD","SQQQ",".IXIC","MNQmain","BVAXF","PLX","BK4179","APRE","ADAP","AEMD","FET","UNCY"],"gpt_icon":1},{"id":"2468795645","title":"Evaxion Biotech Price Target Maintained With a $14.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2468795645","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468795645?lang=en_us&edition=fundamental","pubTime":"2024-09-20 18:45","pubTimestamp":1726829100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EVAX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 20, 2024 06:45 ET (10:45 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX"],"gpt_icon":0},{"id":"2468645638","title":"Buy Rating for Evaxion Biotech Supported by Strong Clinical Results and PIONEER Platform’s Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2468645638","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468645638?lang=en_us&edition=fundamental","pubTime":"2024-09-20 18:25","pubTimestamp":1726827951,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on Evaxion Biotech (EVAX – Research Report) today and set a price target of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/buy-rating-for-evaxion-biotech-supported-by-strong-clinical-results-and-pioneer-platforms-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/buy-rating-for-evaxion-biotech-supported-by-strong-clinical-results-and-pioneer-platforms-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2468571973","title":"Evaxion Biotech Unveils Advanced AI Vaccine Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2468571973","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468571973?lang=en_us&edition=fundamental","pubTime":"2024-09-19 20:57","pubTimestamp":1726750646,"startTime":"0","endTime":"0","summary":"Evaxion Biotech (EVAX) has released an update. Evaxion Biotech, an AI-focused TechBio company, announced the launch of its enhanced AI-Immunology p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-unveils-advanced-ai-vaccine-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-unveils-advanced-ai-vaccine-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AEIS","BK4139","BK4157","IE00B19Z4B17.USD","IE00B66KJ199.SGD","IE00B7SZL793.SGD","IE0031619046.USD","EVAX"],"gpt_icon":0},{"id":"2468734885","title":"Evaxion Launches Improved AI-Immunology™ Platform for Vaccine Antigen Prediction","url":"https://stock-news.laohu8.com/highlight/detail?id=2468734885","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468734885?lang=en_us&edition=fundamental","pubTime":"2024-09-19 20:00","pubTimestamp":1726747203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240919:nTUA8JNFXW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVAX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.evaxionbiotech.com","stockEarnings":[{"period":"1week","weight":-0.0286},{"period":"1month","weight":-0.0408},{"period":"3month","weight":0.0552},{"period":"6month","weight":-0.0438},{"period":"1year","weight":-0.6353},{"period":"ytd","weight":-0.5537}],"compareEarnings":[{"period":"1week","weight":0.0023},{"period":"1month","weight":0.0191},{"period":"3month","weight":0.0516},{"period":"6month","weight":0.0941},{"period":"1year","weight":0.3433},{"period":"ytd","weight":0.2041}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.269805},{"month":2,"riseRate":0,"avgChangeRate":-0.053098},{"month":3,"riseRate":0,"avgChangeRate":-0.133841},{"month":4,"riseRate":0.75,"avgChangeRate":0.137684},{"month":5,"riseRate":0.25,"avgChangeRate":-0.067063},{"month":6,"riseRate":0.25,"avgChangeRate":-0.055002},{"month":7,"riseRate":0.25,"avgChangeRate":0.052601},{"month":8,"riseRate":0.5,"avgChangeRate":-0.067943},{"month":9,"riseRate":1,"avgChangeRate":0.150546},{"month":10,"riseRate":0.333333,"avgChangeRate":0.04085},{"month":11,"riseRate":0,"avgChangeRate":-0.278598},{"month":12,"riseRate":0,"avgChangeRate":-0.126361}],"exchange":"NASDAQ","name":"Evaxion Biotech A/S","nameEN":"Evaxion Biotech A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.28.1","shortVersion":"4.28.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Evaxion Biotech A/S,EVAX,Evaxion Biotech A/S股票,Evaxion Biotech A/S股票老虎,Evaxion Biotech A/S股票老虎国际,Evaxion Biotech A/S行情,Evaxion Biotech A/S股票行情,Evaxion Biotech A/S股价,Evaxion Biotech A/S股市,Evaxion Biotech A/S股票价格,Evaxion Biotech A/S股票交易,Evaxion Biotech A/S股票购买,Evaxion Biotech A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction